Veterinary Orthopedic Medicines Market Size & Growth Forecast 2027–2036, By Segments (Product, Animal Type, Application, Route of Administration, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Orthopedic Medicines Market size was around USD 2 billion in 2026 and is slated to grow at a 8.17% CAGR from 2027 to 2036, exceeding USD 4.39 billion by 2036. The industry revenue for 2027 is calculated at USD 2.14 billion.
Get more details on this report
Request Free Sample ReportVeterinary Orthopedic Medicines Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 42.61% share in 2026, supported by established companion animal care, greater treatment uptake, specialized veterinary services, and routine orthopedic care across clinical settings.
- Asia Pacific is projected to grow at a 9.83% CAGR as veterinary infrastructure expands, treatment availability improves, and adoption of orthopedic therapies increases across urban and developing care networks.
Segment Momentum
- Pharmaceuticals lead with 49.29% share in 2026 due to their routine use in managing pain, inflammation, and recovery across diverse orthopedic conditions in standard veterinary practice.
- Equine is the fastest-growing animal type as horses require specialized, sustained orthopedic care for mobility, lameness, and performance-related joint conditions, increasing targeted therapeutic demand.
Market Expansion Drivers
- Rising prevalence of osteoarthritis and orthopedic disorders in aging pets and animals.
- Increasing adoption of pet insurance improving access to advanced veterinary treatments.
- Growth in regenerative therapies including stem cell treatments for animal joint disorders.
Leading Market Participants
- Leading players in the veterinary orthopedic medicines market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health Incorporated (United States), Merck & Co., Inc. (United States), Virbac S.A. (France), Vetoquinol S.A. (France), Ceva Santé Animale S.A. (France), Dechra Pharmaceuticals PLC (United Kingdom), Bioiberica S.A.U. (Spain), PetVivo Holdings, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2 billion
- 2027 Estimated Market Size: USD 2.14 billion.
- Projected Market Size: USD 4.39 billion by 2036
- Growth Forecast: 8.17% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Pharmaceuticals (Product) | Canine (Animal Type) | Osteoarthritis (Application) | Injectable (Route of Administration) | Veterinary Hospitals (End Use)
- Emerging Opportunity Segment: Viscosupplements (Product) | Equine (Animal Type) | Degenerative Joint Disease (Application) | Injectable (Route of Administration) | Veterinary Clinics (End Use)
Market Growth Drivers and Industry Trends
Rising prevalence of osteoarthritis and orthopedic disorders in aging pets and animals
The veterinary orthopedic medicines market is benefiting from the increasing incidence of osteoarthritis, joint degeneration, and other musculoskeletal disorders among aging companion animals and livestock. As pets live longer, age-related mobility problems are becoming more frequently identified and treated, while larger animal populations also require interventions for orthopedic injuries and chronic joint conditions. Veterinary practitioners are increasingly using anti-inflammatory medicines, pain-management therapies, and joint-support treatments to improve mobility and quality of life. Greater awareness among animal owners regarding the importance of early diagnosis and ongoing management is also encouraging treatment of chronic orthopedic conditions rather than relying solely on supportive care.
Increasing adoption of pet insurance improving access to advanced veterinary treatments
Broader adoption of pet insurance is helping reduce the financial barriers associated with diagnosis and treatment of complex orthopedic conditions, supporting demand in the veterinary orthopedic medicines market. Insurance coverage can make advanced consultations, diagnostic procedures, prescription therapies, and longer treatment regimens more financially accessible to pet owners. This is particularly relevant for orthopedic disorders, which may require repeated veterinary visits and multimodal treatment over extended periods. As insured pet owners become more willing to pursue recommended therapies instead of delaying care because of treatment costs, veterinarians gain greater flexibility in managing chronic joint disorders and postoperative recovery.
Growth in regenerative therapies including stem cell treatments for animal joint disorders
Increasing interest in regenerative medicine is expanding the therapeutic options available for animals affected by chronic joint and orthopedic conditions. Within the veterinary orthopedic medicines market, stem cell-based approaches and related regenerative therapies are attracting attention because they aim to support tissue repair and improve joint function rather than focusing solely on symptom management. These treatments can be particularly relevant for animals with degenerative conditions that require longer-term care or have limited responses to conventional therapies. Growing veterinary research and clinical experience with regenerative approaches are also encouraging the integration of advanced treatment strategies alongside established pain-management and anti-inflammatory protocols.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of osteoarthritis and orthopedic disorders in aging pets and animals | 2.30% | Moderate | North America, Europe | High | Near Term |
| Increasing adoption of pet insurance improving access to advanced veterinary treatments | 2.00% | Moderate | North America, Europe | High | Near Term |
| Growth in regenerative therapies including stem cell treatments for animal joint disorders | 1.70% | High | Europe, North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the veterinary orthopedic medicines market, North America held the largest share of 42.61% in 2026, supported by advanced veterinary healthcare infrastructure, high pet ownership, and strong demand for specialized treatment of musculoskeletal conditions in companion animals. The region benefits from widespread access to veterinary specialists, diagnostic imaging, surgical facilities, and rehabilitation services, enabling more comprehensive management of fractures, osteoarthritis, ligament injuries, and other orthopedic disorders. Growing expenditure on pet healthcare and increasing willingness among owners to pursue advanced treatment options are also strengthening demand for therapeutic medicines used alongside surgical and rehabilitative care. In addition, continued development of veterinary pharmacology and greater emphasis on preventive and long-term animal health management are reinforcing the region's established market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, driven by rising companion animal adoption, expanding veterinary service capacity, and increasing awareness of specialized animal healthcare. Urbanization and changing household structures are encouraging greater spending on pets, while improvements in veterinary education, diagnostic capabilities, and clinical infrastructure are broadening access to orthopedic care. The expansion of organized veterinary practices in developing markets is also improving the availability of prescription medicines and postoperative therapies. Growing recognition of animal welfare and increasing acceptance of advanced treatment for mobility-related conditions are expected to further support regional demand.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Advanced Post-Surgical ManagementGermany emphasizes veterinary orthopedic medicines that support rehabilitation and pain management following orthopedic procedures. German veterinary clinics are incorporating targeted pharmaceutical therapies alongside advanced surgical interventions to improve recovery outcomes in pets.
France 🇫🇷
Integrated Rehabilitation ApproachFrance is adopting veterinary orthopedic medicines within comprehensive rehabilitation strategies for companion animals. Veterinary professionals in France are emphasizing treatment combinations that manage pain effectively and support functional recovery after injury or orthopedic surgery.
Italy 🇮🇹
Small Animal Orthopedic SupportItaly's veterinary orthopedic medicines market is expanding through greater awareness of mobility disorders in dogs and cats. Italian veterinary practices are increasingly using orthopedic medicines as part of long-term management plans designed to improve comfort and daily activity in affected animals.
Japan 🇯🇵
Aging Pet Treatment DemandJapan's veterinary orthopedic medicines market is influenced by an increasing population of aging companion animals requiring chronic joint care. Veterinary providers in Japan are expanding the use of anti-inflammatory and supportive therapies aimed at maintaining mobility and extending active lifespans.
South Korea 🇰🇷
Premium Pet Healthcare ExpansionSouth Korea is witnessing greater demand for veterinary orthopedic medicines as pet owners seek advanced treatment options for musculoskeletal conditions. Clinics in South Korea are broadening orthopedic care offerings and incorporating specialized therapies into companion animal treatment protocols.
United States 🇺🇸
Companion Animal Mobility CareThe U.S. veterinary orthopedic medicines market is shaped by growing demand for treatments that address joint disorders and post-surgical recovery in companion animals. Veterinary practices in the U.S. are increasingly adopting multimodal therapies that improve long-term mobility and quality of life.
Segment Leadership and Growth Trends
Veterinary Orthopedic Medicines Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Pharmaceuticals (Largest Segment) vs Viscosupplements (Fastest-Growing Segment)
Pharmaceuticals held the largest position in the veterinary orthopedic medicines market, representing a 49.29% share in 2026. Their broad use reflects the continuing need for pharmacological management of pain, inflammation, joint disorders, and mobility-related conditions in companion and other animals. Veterinary pharmaceuticals provide established treatment pathways for managing orthopedic conditions while supporting recovery and maintaining quality of life. Increasing attention to animal health, earlier intervention for musculoskeletal disorders, and improved veterinary diagnosis are reinforcing demand for pharmaceutical-based orthopedic care.
The viscosupplements segment is expanding at the fastest pace as veterinarians increasingly emphasize joint preservation and supportive therapies for animals affected by degenerative musculoskeletal conditions. Viscosupplements can improve joint lubrication and cushioning while supporting mobility and reducing discomfort associated with joint deterioration. Their role as a complementary option alongside conventional therapies is particularly relevant as veterinary care shifts toward multimodal and preventive approaches. Growing awareness of long-term mobility management is creating additional opportunities for these products across orthopedic treatment protocols.
Animal Type Segment Analysis: Canine (Largest Segment) vs Equine (Fastest-Growing Segment)
In the veterinary orthopedic medicines market, the canine segment accounted for the largest share of 48.87% in 2026. High demand is supported by the prevalence of orthopedic conditions affecting dogs, including joint degeneration, mobility disorders, and injuries requiring sustained therapeutic management. Increasing pet healthcare spending and greater owner awareness of pain management are encouraging earlier veterinary intervention and continued treatment. The growing emphasis on maintaining mobility and quality of life is also strengthening demand for orthopedic medicines designed for canine patients.
Equine represents the fastest-growing animal type segment, driven by the importance of musculoskeletal health in maintaining mobility, performance, and overall animal welfare. Horses are particularly dependent on sound joint and skeletal function, creating a strong need for therapies addressing inflammation, injury, and degenerative conditions. Veterinary practitioners are increasingly incorporating advanced orthopedic management strategies that combine pharmaceutical and supportive treatments. Greater attention to preventive care, rehabilitation, and long-term mobility preservation is supporting expanding adoption within equine medicine.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Biologics, Viscosupplements, Pharmaceuticals | Pharmaceuticals | Viscosupplements |
| Animal Type | Canine, Equine, Others | Canine | Equine |
| Application | Osteoarthritis, Degenerative Joint Disease, Others | Osteoarthritis | Degenerative Joint Disease |
| Route of Administration | Oral, Injectable, Others | Injectable | Injectable |
| End Use | Veterinary Hospitals, Veterinary Clinics, Others | Veterinary Hospitals | Veterinary Clinics |
Competitive Landscape and Market Positioning
Key companies in the veterinary orthopedic medicines market:
1. Zoetis Inc. (United States)
2. Boehringer Ingelheim International GmbH (Germany)
3. Elanco Animal Health Incorporated (United States)
4. Merck & Co. Inc. (United States)
5. Virbac S.A. (France)
6. Vetoquinol S.A. (France)
7. Ceva Santé Animale S.A. (France)
8. Dechra Pharmaceuticals PLC (United Kingdom)
9. Bioiberica S.A.U. (Spain)
10. PetVivo Holdings Inc. (United States)
Rising awareness of companion animal healthcare is fostering innovation within the veterinary orthopedic medicines market. Research focused on advanced therapeutics and improved pain management solutions is expanding treatment options while addressing the growing demand for effective musculoskeletal care in veterinary medicine.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Elanco Animal Health Incorporated (United States) | |||||||
| Merck & Co. Inc. (United States) | |||||||
| Virbac S.A. (France) | |||||||
| Vetoquinol S.A. (France) | |||||||
| Ceva Santé Animale S.A. (France) | |||||||
| Dechra Pharmaceuticals PLC (United Kingdom) | |||||||
| Bioiberica S.A.U. (Spain) | |||||||
| PetVivo Holdings Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Movora | Jul-25 | Movora signed an exclusivity agreement with B. Braun VetCare’s Aesculap Division to distribute surgical power systems in the United States and Canada. The partnership expands access to advanced orthopedic surgical tools and strengthens Movora’s positioning in veterinary surgical infrastructure markets. |
| Arthrex | Jun-25 | Arthrex launched the Synergy Power System, a battery-powered surgical system featuring ergonomic drill and saw handpieces for orthopedic procedures including sports medicine, trauma, and extremity surgery. The launch enhances surgical efficiency and broadens Arthrex’s veterinary-adjacent orthopedic technology portfolio. |
| Zoetis | Feb-25 | Zoetis announced a U.S. label expansion for Librela (bedinvetmab), extending its indication to include broader control of canine osteoarthritis pain. The update enhances treatment accessibility for chronic pain management and strengthens Zoetis’ leadership in monoclonal antibody therapies for veterinary orthopedics. |
| VetStem | Apr-24 | VetStem launched PrecisePRP Canine, an off-the-shelf platelet-rich plasma product for intra-articular administration in dogs. The freeze-dried formulation eliminates the need for blood draws or centrifugation, improving dosing consistency and safety while expanding regenerative orthopedic treatment options in veterinary care. |
| Felix Pharmaceuticals | Apr-24 | Felix Pharmaceuticals received FDA approval for ANADA Carprofen, a nonsteroidal anti-inflammatory drug used to manage pain and inflammation associated with osteoarthritis and post-surgical orthopedic conditions in dogs. The approval strengthens the company’s veterinary pain management portfolio in regulated U.S. markets. |
| Ceva Santé Animale | Jan-24 | Ceva Santé Animale acquired Scout Bio to strengthen its veterinary regenerative medicine capabilities. The acquisition supports development of advanced biologic therapies targeting orthopedic and chronic conditions in companion animals, expanding Ceva’s innovation footprint in animal health therapeutics. |
| PetVivo Holdings | Oct-23 | PetVivo Holdings partnered with Covetrus North America to distribute Spryng with OsteoCushion technology, an injectable device for managing joint pain in animals. The agreement expands U.S. market access and enhances commercial reach through Covetrus’ established veterinary distribution network. |
| Athersys | Oct-23 | Athersys entered a licensing agreement granting Ardent Animal Health exclusive rights to its MAPC stem cell technology for non-human mammal applications in the United States. The deal includes milestone payments and royalties, supporting expansion of regenerative veterinary orthopedic therapies. |
| Zoetis | Oct-22 | Zoetis completed the acquisition of Jurox, an Australian animal health company specializing in veterinary medicines for livestock and companion animals. The acquisition broadens Zoetis’ orthopedic and pain management portfolio and strengthens its global animal health market presence. |
| Boehringer Ingelheim | Apr-22 | Boehringer Ingelheim received European approval for RenuTend, a therapy designed to improve healing of tendon and ligament injuries in horses. The product complements its equine regenerative medicine portfolio and expands treatment options for musculoskeletal conditions in veterinary orthopedics. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Orthopedic Medicines Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Severity | Mild & Early-Stage Conditions, Moderate Conditions, Severe & Advanced Conditions, Post-Surgical & Recovery Cases |
| Therapy Lifecycle Stage | Initial Treatment, Maintenance Therapy, Long-Term Management, Post-Surgical Rehabilitation |
| Distribution Channel | Veterinary Clinics & Hospitals, Veterinary Pharmacies, Distributor & Wholesaler Networks, Online Veterinary Pharmacies |
Veterinary Orthopedic Medicines Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Companion Animal Orthopedic Care Pathway Analysis |
|
| Advanced Treatment Innovation Landscape |
|
| Animal Rehabilitation Market Opportunity Mapping |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the veterinary orthopedic medicines market?
How much is the veterinary orthopedic medicines industry expected to grow by 2036?
How is the rising prevalence of orthopedic disorders in aging animals shaping treatment patterns?
How does pet insurance influence access to advanced veterinary orthopedic treatments?
Why do Pharmaceuticals dominate veterinary orthopedic medicine treatments?
What is driving rapid adoption of Equine orthopedic medicines?
Why does North America dominate the veterinary orthopedic medicines market?
What is driving Asia Pacific's growth in the veterinary orthopedic medicines market?
Who are the leading players in the veterinary orthopedic medicines landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization